ArticleJAMA network open2022

Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial.

Dan-Yu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.